HCA Healthcare’s (HCA) Neutral Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reiterated their neutral rating on shares of HCA Healthcare (NYSE:HCA) in a report released on Tuesday, MarketBeat reports. JPMorgan Chase & Co. currently has a $380.00 target price on the stock.

Other equities research analysts also recently issued reports about the company. Oppenheimer boosted their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Barclays dropped their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. TD Cowen decreased their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Finally, Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.63.

HCA Healthcare Stock Down 0.6 %

HCA stock opened at $307.74 on Tuesday. HCA Healthcare has a twelve month low of $263.22 and a twelve month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a market capitalization of $77.95 billion, a P/E ratio of 13.82, a PEG ratio of 1.21 and a beta of 1.63. The firm has a 50 day simple moving average of $352.47 and a 200-day simple moving average of $358.35.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insiders Place Their Bets

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently modified their holdings of the stock. Terra Nova Asset Management LLC increased its stake in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its position in shares of HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares in the last quarter. Brookstone Capital Management lifted its holdings in shares of HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after purchasing an additional 30 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after buying an additional 30 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.